Article
AstraZeneca's Tagrisso-chemo combo given priority review in US
Rating:
0.0
Views:
52
Likes:
1
Library:
1
A combination of AstraZeneca's blockbuster cancer drug Tagrisso, with chemotherapy to treat a type of lung cancer, has been accepted and granted priority review by the U.S. Food and Drug Administration (FDA), the British drugmaker said on Monday.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value